Jurgi Camblong is the CEO and co-founder of SOPHiA GENETICS, a company at the forefront of data-driven medicine. With a background in molecular biology and a PhD in Life Sciences, Camblong has led SOPHiA GENETICS to become a key player in the healthcare industry, recognized for its innovative solutions in genetic analysis.
Who is the CEO of SOPHiA GENETICS?
Jurgi Camblong, a molecular biologist with a PhD in Life Sciences from the University of Geneva and an EMBA in Management of Technology from EPFL/HEC Lausanne, is the CEO and co-founder of SOPHiA GENETICS. His career is marked by significant contributions to the field of data-driven medicine, with numerous publications in prestigious journals such as Cell, Science, and Nature. Since founding SOPHiA GENETICS in 2011, Camblong has been instrumental in its growth, leading the company to be recognized among the 50 smartest companies by the MIT Technology Review and earning accolades such as the EY Emergent Entrepreneur of the Year.
Work History
Jurgi Camblong's work history includes a series of notable positions in the field of genetics and molecular biology. Here is a list of the places he has worked previously:
- SOPHiA GENETICS - Co-Founder and CEO (2011 - Present)
- Gene Predictis - CEO (2010 - 2011)
- Oxford University, UK - Post-doctoral Associate Researcher (2008 - 2010)
- University of Geneva - Post-doctoral Associate Researcher (2007 - 2008)
Education History
Jurgi Camblong's educational journey is both extensive and diverse, reflecting his deep commitment to the field of molecular biology and business management. He began his academic career at the Université de Pau et des Pays de l'Adour, where he earned a Master's degree in Biochemistry from 1997 to 2001. He then pursued a DEA in Health Biology at the Université de Bordeaux, completing it in 2002. Camblong continued his studies at the University of Geneva, obtaining a PhD in Molecular Biology between 2002 and 2007, and later a Certificate in Marketing and Business Analysis in 2006. To further enhance his expertise in technology management, he completed an EMBA in Management of Technology at HEC-EPFL Lausanne from 2011 to 2012.
When did Jurgi Camblong join SOPHiA GENETICS?
Jurgi Camblong co-founded SOPHiA GENETICS in March 2011 and has been serving as its CEO since its inception. With a tenure spanning over 12 years, Camblong has been instrumental in steering the company towards becoming a leader in data-driven medicine.
His continuous leadership has been pivotal in the company's growth and innovation in genetic analysis, making significant strides in healthcare technology.